148 related articles for article (PubMed ID: 21538476)
21. Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice.
Botolin S; Faugere MC; Malluche H; Orth M; Meyer R; McCabe LR
Endocrinology; 2005 Aug; 146(8):3622-31. PubMed ID: 15905321
[TBL] [Abstract][Full Text] [Related]
22. Combination breast cancer chemotherapy with doxorubicin and cyclophosphamide damages bone and bone marrow in a female rat model.
Fan C; Georgiou KR; Morris HA; McKinnon RA; Keefe DMK; Howe PR; Xian CJ
Breast Cancer Res Treat; 2017 Aug; 165(1):41-51. PubMed ID: 28550626
[TBL] [Abstract][Full Text] [Related]
23. Overexpression of BCLXL in Osteoblasts Inhibits Osteoblast Apoptosis and Increases Bone Volume and Strength.
Moriishi T; Fukuyama R; Miyazaki T; Furuichi T; Ito M; Komori T
J Bone Miner Res; 2016 Jul; 31(7):1366-80. PubMed ID: 26852895
[TBL] [Abstract][Full Text] [Related]
24. Differential response of bone and kidney to ACEI in db/db mice: A potential effect of captopril on accelerating bone loss.
Zhang Y; Li XL; Sha NN; Shu B; Zhao YJ; Wang XL; Xiao HH; Shi Q; Wong MS; Wang YJ
Bone; 2017 Apr; 97():222-232. PubMed ID: 28130181
[TBL] [Abstract][Full Text] [Related]
25. Reduced bone formation in alcohol-induced osteopenia is associated with elevated p21 expression in bone marrow cells in aldehyde dehydrogenase 2-disrupted mice.
Shimizu Y; Sakai A; Menuki K; Mori T; Isse T; Oyama T; Kawamoto T; Nakamura T
Bone; 2011 May; 48(5):1075-86. PubMed ID: 21256255
[TBL] [Abstract][Full Text] [Related]
26. Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis.
Kawashima Y; Fritton JC; Yakar S; Epstein S; Schaffler MB; Jepsen KJ; LeRoith D
Bone; 2009 Apr; 44(4):648-55. PubMed ID: 19150422
[TBL] [Abstract][Full Text] [Related]
27. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function.
Hamann C; Goettsch C; Mettelsiefen J; Henkenjohann V; Rauner M; Hempel U; Bernhardt R; Fratzl-Zelman N; Roschger P; Rammelt S; Günther KP; Hofbauer LC
Am J Physiol Endocrinol Metab; 2011 Dec; 301(6):E1220-8. PubMed ID: 21900121
[TBL] [Abstract][Full Text] [Related]
28. Early response of bone marrow osteoprogenitors to skeletal unloading and sclerostin antibody.
Shahnazari M; Wronski T; Chu V; Williams A; Leeper A; Stolina M; Ke HZ; Halloran B
Calcif Tissue Int; 2012 Jul; 91(1):50-8. PubMed ID: 22644321
[TBL] [Abstract][Full Text] [Related]
29. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
Iida-Klein A; Zhou H; Lu SS; Levine LR; Ducayen-Knowles M; Dempster DW; Nieves J; Lindsay R
J Bone Miner Res; 2002 May; 17(5):808-16. PubMed ID: 12009011
[TBL] [Abstract][Full Text] [Related]
30. Accelerated bone formation and increased osteoblast number contribute to the abnormal tooth germ development in parathyroid hormone-related protein knockout mice.
Kitahara Y; Suda N; Terashima T; Baba O; Mekaapiruk K; Hammond VE; Takano Y; Ohyama K
Bone; 2004 Nov; 35(5):1100-6. PubMed ID: 15542035
[TBL] [Abstract][Full Text] [Related]
31. Caspase-2 maintains bone homeostasis by inducing apoptosis of oxidatively-damaged osteoclasts.
Sharma R; Callaway D; Vanegas D; Bendele M; Lopez-Cruzan M; Horn D; Guda T; Fajardo R; Abboud-Werner S; Herman B
PLoS One; 2014; 9(4):e93696. PubMed ID: 24691516
[TBL] [Abstract][Full Text] [Related]
32. Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice.
Feng W; Liu B; Liu D; Hasegawa T; Wang W; Han X; Cui J; Yimin ; Oda K; Amizuka N; Li M
J Histochem Cytochem; 2016 Jan; 64(1):42-53. PubMed ID: 26416243
[TBL] [Abstract][Full Text] [Related]
33. Both spontaneous Ins2(+/-) and streptozotocin-induced type I diabetes cause bone loss in young mice.
Coe LM; Zhang J; McCabe LR
J Cell Physiol; 2013 Apr; 228(4):689-95. PubMed ID: 22886636
[TBL] [Abstract][Full Text] [Related]
34. Ablation of p38α MAPK Signaling in Osteoblast Lineage Cells Protects Mice From Bone Loss Induced by Estrogen Deficiency.
Thouverey C; Caverzasio J
Endocrinology; 2015 Dec; 156(12):4377-87. PubMed ID: 26441240
[TBL] [Abstract][Full Text] [Related]
35. Osteoblast-specific deletion of Pkd2 leads to low-turnover osteopenia and reduced bone marrow adiposity.
Xiao Z; Cao L; Liang Y; Huang J; Stern AR; Dallas M; Johnson M; Quarles LD
PLoS One; 2014; 9(12):e114198. PubMed ID: 25464512
[TBL] [Abstract][Full Text] [Related]
36. Coenzyme q10 regulates osteoclast and osteoblast differentiation.
Moon HJ; Ko WK; Jung MS; Kim JH; Lee WJ; Park KS; Heo JK; Bang JB; Kwon IK
J Food Sci; 2013 May; 78(5):H785-891. PubMed ID: 23582186
[TBL] [Abstract][Full Text] [Related]
37. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
Sasaki T
Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
[TBL] [Abstract][Full Text] [Related]
38. Expression of the calcitonin receptor in bone marrow cell cultures and in bone: a specific marker of the differentiated osteoclast that is regulated by calcitonin.
Lee SK; Goldring SR; Lorenzo JA
Endocrinology; 1995 Oct; 136(10):4572-81. PubMed ID: 7664679
[TBL] [Abstract][Full Text] [Related]
39. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
40. Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice.
Motyl KJ; McCabe LR
J Cell Physiol; 2009 Feb; 218(2):376-84. PubMed ID: 18932203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
